Disarming HIV with a 'pop'

Drexel researchers create molecule that can trick HIV into destroying itself

2013-09-20

(Press-News.org) VIDEO: The Dual Action Virolytic Entry Inhibitor (DAVEI) molecule tricks HIV into popping itself by making it behave as if it's attached to a healthy cell. DAVEI triggers the virus to...
Click here for more information.

Pinning down an effective way to combat the spread of the human immunodeficiency virus, the viral precursor to AIDS, has long been challenge task for scientists and physicians, because the virus is an elusive one that mutates frequently and, as a result, quickly becomes immune to medication. A team of Drexel University researchers is trying to get one step ahead of the virus with a microbicide they've created that can trick HIV into "popping" itself into oblivion.

Its name is DAVEI - which stands for "Dual Action Virolytic Entry Inhibitor"- and it can pull a fast one on HIV. DAVEI was invented and tested by scientists from Drexel's College of Engineering; School of Biomedical Engineering, Science and Health Systems; and College of Medicine, and is the latest in a new generation of HIV treatments that function by specifically destroying the virus without harming healthy cells.

"While several molecules that destroy HIV have recently been announced, DAVEI is unique among them by virtue of its design, specificity and high potency," said Dr. Cameron Abrams, a professor in Drexel's College of Engineering and a primary investigator of the project.

A team co-led by Abrams and Dr. Irwin Chaiken in the Department of Biochemistry and Molecular Biology in Drexel's College of Medicine, and including Dr. Mark Contarino and doctoral students Arangassery Rosemary Bastian and R. V. Kalyana Sundaram, developed the chimeric recombinantly engineered protein – that is, a molecule assembled from pieces of other molecules and engineered for a specific purpose, in this case to fight HIV. Their research will be published in the October edition of the American Society for Microbiology's Antimicrobial Agents and Chemotherapy.

The idea behind DAVEI was to design a molecule that hijacks the virus's fusion machinery, the tools it uses to attach to and attack a healthy cell, and trick the virus into destroying itself. HIV invades a healthy cell by first attaching via protein "spikes" that then collapse to pull viral and cell membranes together, fusing them and allowing the genetic contents of the virus to enter the healthy cell. The cell is rewired by the viral genetic material into producing more viruses instead of performing its normal function, which, in the case of cells infected by HIV, involves normal immunity. AIDS is the result.

"We hypothesized that an important role of the fusion machinery is to open the viral membrane when triggered, and it follows that a trigger didn't necessarily have to be a doomed cell," Abrams said. "So we envisioned particular ways the components of the viral fusion machinery work and designed a molecule that would trigger it prematurely," Abrams said.

They designed DAVEI from two main ingredients. One piece, called the Membrane Proximal External Region (MPER), is itself a small piece of the fusion machinery and interacts strongly with viral membranes. The other piece, called cyanovirin, binds to the sugar coating of the protein spike. Working together, the MPER and cyanovirin in DAVEI "tweak" the fusion machinery in a way that mimics the forces it feels when attached to a cell.

"For lack of a better term, DAVEI 'tricks' the virus into 'thinking' it is about to infect a healthy cell, when, in fact, there is nothing there for it to infect," Abrams said. "Instead, it releases its genetic payload harmlessly and dies."

Chaiken's lab has extensively investigated the molecular mechanisms of HIV-1 envelope protein interactions and structure-based design of agents that fight HIV. The researchers produced DAVEI by recombinant protein engineering and used HIV-1 pseudoviruses to demonstrate that it can physically rupture and irreversibly inactivate the virus particles.

"DAVEI and other new-generation virolytic inactivators open up an important opportunity to develop a topical microbicide to block the transmission of HIV, and at the same time provide lead ideas to discover treatment strategies for people who are already infected," Chaiken said. "Our hope is that determining the structural driving forces of both inhibitors and viral entry machinery that enable spike inactivation will help to advance molecular designs with increased power, specificity and clinical potential for both prevention and treatment."

INFORMATION:

ELSE PRESS RELEASES FROM THIS DATE:

Could dog food additive prevent disabling chemotherapy side effect?

2013-09-20

Working with cells in test tubes and in mice, researchers at Johns Hopkins have discovered that a chemical commonly used as a dog food preservative may prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol. The Food and Drug Administration-approved preservative, an antioxidant called ethoxyquin, was shown in experiments to bind to certain cell proteins in a way that limits their exposure to the damaging effects of Taxol, the researchers say. The hope, they say, is to build on the protective ...

NIH study establishes benefits of bracing in adolescents with idiopathic scoliosis

2013-09-20

Bracing in adolescents with idiopathic scoliosis reduces the likelihood that the condition will progress to the point that surgery is needed, according to a study published online today in the New England Journal of Medicine. The work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health. Adolescent idiopathic scoliosis (AIS) is a curvature of the spine with no clear underlying cause. In mild cases, monitoring over time by a physician may be all that is needed. However, in more severe ...

First real-time detector for IV delivered drugs may help eliminate life-threatening medical errors

2013-09-20

WASHINGTON, Sept. 19, 2013—Today, computerized smart systems can deliver drugs intravenously in exact volumes to hospital patients. However, these systems cannot recognize which medications are in the tubing nor can they determine the concentration of the drug in the tubing. This lack of precise information can lead to medication errors with serious consequences. Now, a new optical device developed by a team of electrical and computer engineering students at the University of Illinois at Urbana-Champaign (UIUC) can identify the contents of the fluid in an intravenous ...

Algae biofuel cuts CO2 emissions more than 50 percent compared to petroleum

2013-09-20

MINNEAPOLIS (September 19, 2013) –Algae-derived biofuel can reduce life cycle CO2 emissions by 50 to 70 percent compared to petroleum fuels, and is approaching a similar Energy Return on Investment (EROI) as conventional petroleum according to a new peer-reviewed paper published in Bioresource Technology. The study, which is the first to analyze real-world data from an existing algae-to-energy demonstration scale farm, shows that the environmental and energy benefits of algae biofuel are at least on par, and likely better, than first generation biofuels. "This study affirms ...

Antibacterial products fuel resistant bacteria in streams and rivers

2013-09-20

(Millbrook, N.Y.) Triclosan – a synthetic antibacterial widely used in personal care products – is fueling the development of resistant bacteria in streams and rivers. So reports a new paper in the journal Environmental Science and Technology, which is the first to document triclosan resistance in a natural environment. Invented for surgeons in the 1960s, triclosan slows or stops the growth of bacteria, fungi, and mildew. Currently, around half of liquid soaps contain the chemical, as well as toothpastes, deodorants, cosmetics, liquid cleansers, and detergents. Triclosan ...

Overfishing of sharks is harming coral reefs

2013-09-20

A team of scientists from Canada and Australia has discovered that a decline in shark populations is detrimental to coral reefs. "Where shark numbers are reduced due to commercial fishing, there is also a decrease in the herbivorous fishes which play a key role in promoting reef health," said Jonathan Ruppert, a recent University of Toronto PhD graduate. Ruppert was part of a team engaged in long-term monitoring of reefs off Australia's northwest coast. Team leader Mark Meekan, of the Australian Institute of Marine Science (AIMS), said that the results might, at first ...

Can financial incentives inspire exercise?

2013-09-20

TORONTO, ON - When it comes to sticking to an exercise plan, we're all looking for solutions to ensure that new healthy habits transform into long-term lifestyle changes. PhD candidate Marc Mitchell has published findings in the September online issue of the American Journal of Preventive Medicine suggesting that receiving coupons and vouchers for as little as five dollars can help people stick to new fitness regimes. Under the guidance of Professors Jack Goodman and Guy Faulkner, Mitchell has completed a systematic review of research into the efficacy of financial ...

Carbon monoxide could hold promise of effective preeclampsia treatment, prevention

2013-09-20

Bethesda, Md. (Sept. 19, 2013)—Preeclampsia (PE) is a high blood pressure disorder that occurs during pregnancy and which can cause illness or death for the fetus and mother-to-be. There is currently no cure except to deliver the fetus, perhaps prematurely, or remove the placenta, a key organ that binds the pair. Women who smoke during pregnancy have been found to have as much as a 33 percent lower rate of preeclampsia for reasons that are unclear. A new study using an animal model to mimic key effects of PE in humans, and led by Graeme Smith of Queen's University, Canada, ...

Mayo Clinic researchers identify biomarker for smoker's lung cancer

2013-09-20

ROCHESTER, Minn. -- Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein — ASCL1 — is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET. The findings appear in the online issue of the journal Oncogene. "This is exciting because we've found what we believe to be a 'drugable target' here," says George Vasmatzis, Ph.D., a Mayo Clinic molecular medicine researcher and senior author on the study. "It's a clear biomarker ...

Southwestern Gulf system 95L targeted by NASA's Global Hawk

2013-09-20

NASA's Aqua satellite passed over a developing low pressure area in the southwestern Gulf of Mexico and captured infrared data on what is now the latest destination for NASA's Hurricane and Severe Storms Sentinel mission. On Sept. 19, NASA's HS3 mission sent an unmanned Global Hawk aircraft to investigate and gather data from low pressure System 95L, located in the Bay of Campeche. On Sept. 19 at 07:35 UTC/3:35 a.m. EDT, NASA's Aqua satellite passed over System 95L and the Atmospheric Infrared Sounder instrument or AIRS instrument that flies aboard it captured infrared ...

LAST 30 PRESS RELEASES:

How stepping into nature affects the brain

Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds